Latest Intellectual Property News

Singular Health Group reported a 55% rise in net loss to $2.97 million for H1 FY2026, driven by share-based payments and strategic hires, while making significant progress in US commercial deployments and securing FDA clearance for its cloud-based 3D medical imaging platform.

Electro Optic Systems reported a 27% revenue drop to $128.5 million in FY2025 but posted a net profit of $18.6 million, boosted by the sale of EM Solutions. The company strengthened its position with key contract wins and acquisitions, including the UK-based Interceptor business and a conditional deal for MARSS.

Mesoblast Limited is set to release its half-year financial results and operational update, spotlighting its FDA-approved cell therapy and expanding international partnerships.

Arovella Therapeutics reported a 22% increase in half-year losses to $1.88 million while securing FDA acceptance of its IND application for lead asset ALA-101, paving the way for first-in-human trials.

PlaySide Studios has secured a global publishing agreement with Swedish developer MVRX Games for the upcoming co-op platformer 'Dew', aiming for a 2028 PC and console release. This deal marks a strategic expansion of PlaySide’s publishing portfolio, backed by a multi-million AUD investment.

PLS Group has acquired Calix’s stake in their joint lithium processing venture, gaining full ownership and operational control while securing a royalty-free licence for Calix’s calciner technology.

IDT Australia Limited has reported a significant narrowing of its half-year loss to $1.3 million, driven by stable revenues and operational efficiencies. The pharmaceutical manufacturer highlights growth in key segments despite some timing setbacks.

EZZ Life Science Holdings has secured a four-year exclusive global distribution agreement with Aumake Limited, committing to at least A$10 million in purchases. This partnership aims to accelerate EZZ’s international reach while preserving brand control.

Nanoveu Limited has secured exclusive evaluation rights to four cutting-edge autonomous drone navigation technologies from Nanyang Technological University, aiming to advance GPS-free multi-drone coordination and endurance.

BrainChip has launched its AKD2500 silicon development project, advancing its Akida™ 2.0 neuromorphic AI platform with a $2.5 million investment and prototype expected by Q3 2026.

AVITA Medical reported an 11% increase in sales revenue for 2025, driven by deeper market penetration and new product launches, while reducing its net loss by 21%. The company secured a $60 million senior secured credit facility but flagged substantial doubt about its ability to continue as a going concern.

iCandy Interactive’s subsidiary Lemon Sky Studios has appointed a seasoned industry leader to drive global partnerships, secured over A$1 million in recent contracts, and is exploring strategic options to unlock shareholder value.